Salarius Pharmaceuticals (SLRX) Short Interest Ratio & Short Volume $1.45 -0.03 (-2.03%) (As of 11/4/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Salarius Pharmaceuticals Short Interest DataSalarius Pharmaceuticals (SLRX) has a short interest of 1,500 shares, representing 0.11% of the float (the number of shares available for trading by the public). This marks a -90.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 818,189 shares to cover all short positions.Current Short Interest1,500 sharesPrevious Short Interest15,000 sharesChange Vs. Previous Month-90.00%Dollar Volume Sold Short$2,280.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares1,440,000 sharesFloat Size1,400,000 sharesShort Percent of Float0.11%Today's Trading Volume62,220 sharesAverage Trading Volume818,189 sharesToday's Volume Vs. Average8% Short Selling Salarius Pharmaceuticals? Sign up to receive the latest short interest report for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSLRX Short Interest Over TimeSLRX Days to Cover Over TimeSLRX Percentage of Float Shorted Over Time Ad Porter & CompanyRigged election? Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election. With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late. Watch this video, it is being taken down Monday night Salarius Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20241,500 shares $2,280.00 -90.0%0.1%0 $1.52 9/30/202415,000 shares $21,600.00 +59.6%1.1%0 $1.44 9/15/20249,400 shares $14,664.00 -38.6%0.7%0 $1.56 8/31/202415,300 shares $25,398.00 -64.0%1.1%0 $1.66 8/15/202442,500 shares $85,425.00 -50.8%3.2%0 $2.01 7/31/202486,300 shares $220,928.00 +44.1%15.4%0 $2.56 Get the Latest News and Ratings for SLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/15/202459,900 shares $106,622.00 +215.3%10.7%0 $1.78 6/30/202419,000 shares $45,220.00 +375.0%27.1%0.9 $2.38 6/15/20244,000 shares $13,526.40 -85.4%5.7%0.2 $3.38 5/31/202427,300 shares $12,645.36 -18.5%0.6%0.2 $0.46 5/15/202433,500 shares $15,343.00 -54.5%0.8%0.3 $0.46 4/30/202473,600 shares $36,726.40 -36.3%1.7%0.6 $0.50 4/15/2024115,600 shares $57,800.00 -57.0%2.6%1 $0.50 3/31/2024268,900 shares $142,140.54 +1,767.4%6.7%2.4 $0.53 3/15/202414,400 shares $9,360.00 -20.0%0.4%0.1 $0.65 2/29/202418,000 shares $12,060.00 +227.3%0.5%0.6 $0.67 2/15/20245,500 shares $3,245.00 -33.7%0.2%0.2 $0.59 1/31/20248,300 shares $4,556.70 +36.1%0.2%0.2 $0.55 1/15/20246,100 shares $3,721.00 -37.1%0.2%0.2 $0.61 12/31/20239,700 shares $6,305.00 +38.6%0.3%0.3 $0.65 12/15/20237,000 shares $4,515.00 -71.9%0.2%0.1 $0.65 11/30/202324,900 shares $17,679.00 -56.0%0.7%0.4 $0.71 11/15/202356,600 shares $40,752.00 -22.7%1.6%1.1 $0.72 10/31/202373,200 shares $61,334.28 +136.9%2.3%1.2 $0.84 10/15/202330,900 shares $21,321.00 +62.6%0.9%0.5 $0.69 9/30/202319,000 shares $12,500.08 -6.4%0.6%0.3 $0.66 9/15/202320,300 shares $17,395.07 -26.5%0.6%0.4 $0.86 8/31/202327,600 shares $24,285.24 +162.9%0.8%0.5 $0.88 8/15/202310,500 shares $7,490.70 +54.4%0.3%0.2 $0.71 7/31/20236,800 shares $6,249.20 -60.9%0.2%0.1 $0.92 7/15/202317,400 shares $19,314.00 -44.8%0.6%0.2 $1.11 6/30/202331,500 shares $46,935.00 -41.2%1.0%0.3 $1.49 6/15/202353,600 shares $85,224.00 +9.6%1.7%0.5 $1.59 5/31/202348,900 shares $68,949.00 -48.4%2.1%0.5 $1.41 5/15/202394,700 shares $136,368.00 -16.1%4.2%1 $1.44 4/30/2023112,800 shares $200,784.00 -11.9%5.4%1.3 $1.78 4/15/2023128,000 shares $220,160.00 +6.1%6.1%2.5 $1.72 3/31/2023120,700 shares $230,537.00 -4.2%5.8%0.8 $1.91 3/15/2023126,000 shares $255,780.00 -4.0%6.6%0.7 $2.03 2/28/2023131,300 shares $279,669.00 +16.7%6.8%0.7 $2.13Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 2/15/2023112,500 shares $252,000.00 +11.3%5.9%0.6 $2.24 1/31/2023101,100 shares $260,838.00 +37.7%5.2%0.6 $2.58 1/15/202373,400 shares $194,510.00 +272.6%3.8%0.4 $2.65 12/30/202219,700 shares $30,141.00 -46.6%1.0%0.3 $1.53 12/15/202236,900 shares $55,719.00 +93.2%1.9%0.8 $1.51 11/30/202219,100 shares $36,863.00 -12.0%1.0%0.4 $1.93 11/15/202221,700 shares $46,655.00 +100.9%1.1%0.5 $2.15 10/31/202210,800 shares $21,924.00 -31.2%0.5%0.3 $2.03 10/15/202215,700 shares $71,042.50 -95.8%0.8%0.4 $4.53 9/30/2022371,000 shares $72,345.00 -8.4%N/A0.9 $0.20 9/15/2022405,000 shares $95,904.00 +9.6%N/A0.8 $0.24 8/31/2022369,500 shares $74,269.50 -16.3%N/A0.7 $0.20 8/15/2022441,600 shares $99,360.00 +257.3%N/A0.7 $0.23 7/31/2022123,600 shares $23,508.72 +7.3%N/A0.1 $0.19 7/15/2022115,200 shares $21,876.48 -33.8%N/A0.1 $0.19 6/30/2022174,100 shares $36,561.00 -54.6%N/A0.1 $0.21 6/15/2022383,300 shares $77,733.24 -9.8%N/A0.3 $0.20 5/31/2022425,000 shares $76,627.50 -3.8%N/A0.4 $0.18 5/15/2022441,800 shares $83,014.22 -26.6%N/A0.4 $0.19 4/30/2022602,200 shares $121,644.40 +31.4%N/A1.1 $0.20 4/15/2022458,300 shares $163,658.93 -14.7%N/A1.1 $0.36 3/31/2022537,100 shares $213,819.51 +11.7%N/A1.3 $0.40 3/15/2022480,900 shares $165,429.60 -23.8%N/A1 $0.34 2/28/2022630,900 shares $252,423.09 +0.4%N/A1.8 $0.40 2/15/2022628,200 shares $285,831.00 -3.7%N/A1.7 $0.46 1/31/2022652,400 shares $293,580.00 -2.0%4.5%1.5 $0.45 1/15/2022665,600 shares $312,832.00 +4.2%4.6%1.4 $0.47 12/31/2021638,500 shares $316,440.60 -7.3%4.4%1.3 $0.50 12/15/2021688,600 shares $365,853.18 -35.0%4.7%1.4 $0.53 11/30/20211,060,000 shares $689,000.00 +1.0%7.3%1.5 $0.65 11/15/20211,050,000 shares $796,950.00 +7.5%7.2%1.1 $0.76 10/29/2021976,600 shares $808,331.82 -0.2%6.7%0.8 $0.83 10/15/2021978,900 shares $886,002.39 -24.1%6.7%0.8 $0.91 9/30/20211,290,000 shares $1.32 million -4.4%8.9%1 $1.02 9/15/20211,350,000 shares $1.39 million -2.9%9.3%1 $1.03 8/31/20211,390,000 shares $1.45 million +9.5%9.6%1 $1.04 8/13/20211,270,000 shares $1.17 million -8.0%8.8%0.7 $0.92 7/30/20211,380,000 shares $1.12 million -9.2%9.5%0.8 $0.81 7/15/20211,520,000 shares $1.38 million -19.2%10.5%0.9 $0.91 6/30/20211,880,000 shares $1.99 million +0.5%13.0%1.1 $1.06 6/15/20211,870,000 shares $2.24 million +14.7%12.9%1.1 $1.20 5/28/20211,630,000 shares $2.09 million -2.4%11.3%1 $1.28 5/14/20211,670,000 shares $2.04 million +29.5%N/A1.3 $1.22 4/30/20211,290,000 shares $1.72 million -5.8%N/A0.6 $1.33 4/15/20211,370,000 shares $1.78 million -12.7%N/A0.6 $1.30 3/31/20211,570,000 shares $2.25 million +41.4%N/A0.6 $1.43 3/15/20211,110,000 shares $1.81 million -41.6%N/A0.4 $1.63 2/26/20211,900,000 shares $3.67 million +15.2%N/A0.7 $1.93 2/12/20211,650,000 shares $4.36 million +202.6%N/A0.6 $2.64 1/29/2021545,200 shares $594,268.00 -11.3%N/A0.3 $1.09Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 1/15/2021614,300 shares $712,588.00 +7.3%N/A0.6 $1.16 12/31/2020572,800 shares $510,937.60 +22.8%N/A0.7 $0.89 12/15/2020466,600 shares $407,295.14 -2.1%N/A0.8 $0.87 11/30/2020476,400 shares $325,857.60 -18.6%N/A1.1 $0.68 11/15/2020585,000 shares $427,050.00 +3.0%N/A3.9 $0.73 10/30/2020568,000 shares $382,434.40 -11.4%N/A3.6 $0.67 10/15/2020640,800 shares $583,128.00 -5.2%N/A2.8 $0.91 9/30/2020675,900 shares $570,392.01 +22.7%N/A2.9 $0.84 9/15/2020551,100 shares $506,736.45 -4.2%N/A2.2 $0.92 8/31/2020575,000 shares $540,500.00 +1.4%N/A1.6 $0.94 8/14/2020567,000 shares $569,835.00 -40.8%N/A1 $1.01 7/31/2020958,000 shares $1.10 million +3.7%N/A1.4 $1.15 7/15/2020924,200 shares $1.22 million -6.1%N/A1.3 $1.32 6/30/2020984,200 shares $1.30 million +0.6%N/A1.4 $1.32 6/15/2020978,400 shares $1.50 million +48.5%N/A1.4 $1.53 5/29/2020659,000 shares $691,950.00 +120.0%N/A1.1 $1.05 5/15/2020299,600 shares $254,689.96 +14.5%N/A0.7 $0.85 4/30/2020261,700 shares $217,237.17 +38.0%N/A0.6 $0.83 4/15/2020189,600 shares $117,589.92 +83.5%N/A0.6 $0.62 3/31/2020103,300 shares $65,079.00 +37.4%N/A0.4 $0.63 3/13/202075,200 shares $51,888.00 +89.4%N/A0.3 $0.69 2/28/202039,700 shares $24,614.00 +146.6%N/A0.1 $0.62 2/14/202016,100 shares $12,558.00 -89.4%0.5%0.1 $0.78 1/31/2020151,700 shares $131,979.00 +89.9%4.8%0.9 $0.87 1/15/202079,900 shares $67,116.00 -24.4%2.5%1.2 $0.84 12/31/2019105,700 shares $288,561.00 +101.7%3.7%1.8 $2.73 SLRX Short Interest - Frequently Asked Questions What is Salarius Pharmaceuticals' current short interest? Short interest is the volume of Salarius Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 1,500 shares of SLRX short. 0.11% of Salarius Pharmaceuticals' shares are currently sold short. Learn More on Salarius Pharmaceuticals' current short interest. What is a good short interest percentage for Salarius Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.11% of Salarius Pharmaceuticals' floating shares are currently sold short. Is Salarius Pharmaceuticals' short interest increasing or decreasing? Salarius Pharmaceuticals saw a decrease in short interest during the month of October. As of October 15th, there was short interest totaling 1,500 shares, a decrease of 90.0% from the previous total of 15,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Salarius Pharmaceuticals' float size? Salarius Pharmaceuticals currently has issued a total of 1,440,000 shares. Some of Salarius Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Salarius Pharmaceuticals currently has a public float of 1,400,000 shares. How does Salarius Pharmaceuticals' short interest compare to its competitors? 0.11% of Salarius Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Salarius Pharmaceuticals: Sonoma Pharmaceuticals, Inc. (6.05%), TransCode Therapeutics, Inc. (7.08%), Imunon, Inc. (2.47%), ABVC BioPharma, Inc. (1.31%), Viracta Therapeutics, Inc. (3.97%), Alterity Therapeutics Limited (0.07%), Cyclerion Therapeutics, Inc. (0.58%), Galecto, Inc. (0.90%), Pulmatrix, Inc. (0.18%), Coeptis Therapeutics Holdings, Inc. (0.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Salarius Pharmaceuticals stock? Short selling SLRX is an investing strategy that aims to generate trading profit from Salarius Pharmaceuticals as its price is falling. SLRX shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Salarius Pharmaceuticals? A short squeeze for Salarius Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SLRX, which in turn drives the price of the stock up even further. How often is Salarius Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLRX, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies SNOA Short Interest RNAZ Short Interest IMNN Short Interest ABVC Short Interest VIRX Short Interest ATHE Short Interest CYCN Short Interest GLTO Short Interest PULM Short Interest COEP Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLRX) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salarius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Salarius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLRX Stock Alerts